Literature DB >> 2847075

Effects of cholecystokinin and pentagastrin on rat hippocampal neurones maintained in vitro.

P R Boden1, R G Hill.   

Abstract

Extracellular and intracellular recordings from CA1 neurones of rat hippocampal slices were undertaken to assess the relative potencies of cholecystokinin fragments. The CCK peptides displayed a large variability in their effects on extracellularly recorded population spikes. Intracellular recordings from CA1 neurones revealed a more consistent excitant action of these compounds. The C-terminal octapeptide CCK-8S, the tetrapeptide CCK-4 and pentagastrin were all found to be agonists when applied to hippocampal CA1 neurones maintained in vitro. Repeated application of the peptide fragments to the same cell resulted in a loss of activity. Neurones pre-treated with a CCK peptide showed no response to an application of a second, different, CCK fragment indicative of receptor cross-desensitization. Depolarisations induced by the excitatory amino acid L-glutamate remained unaffected by peptide application. These data suggest that the CCK fragments are agonists at rat CA1 neurones and share a common mode of action distinct from that of the excitatory amino acid L-glutamate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2847075     DOI: 10.1016/0143-4179(88)90037-6

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  11 in total

Review 1.  Cholecystokinin receptors.

Authors:  P Boden; M D Hall; J Hughes
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

2.  Cholecystokinin increases GABA release by inhibiting a resting K+ conductance in hippocampal interneurons.

Authors:  K K Miller; A Hoffer; K R Svoboda; C R Lupica
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

3.  Cholecystokinin facilitates glutamate release by increasing the number of readily releasable vesicles and releasing probability.

Authors:  Pan-Yue Deng; Zhaoyang Xiao; Archana Jha; David Ramonet; Toshimitsu Matsui; Michael Leitges; Hee-Sup Shin; James E Porter; Jonathan D Geiger; Saobo Lei
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

4.  Requirement for CB1 but not GABAB receptors in the cholecystokinin mediated inhibition of GABA release from cholecystokinin expressing basket cells.

Authors:  Sang-Hun Lee; Ivan Soltesz
Journal:  J Physiol       Date:  2010-12-20       Impact factor: 5.182

5.  Rat hippocampal neurons are critically involved in physiological improvement of memory processes induced by cholecystokinin-B receptor stimulation.

Authors:  A Sebret; I Léna; D Crété; T Matsui; B P Roques; V Daugé
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

6.  Increased cholecystokinin labeling in the hippocampus of a mouse model of epilepsy maps to spines and glutamatergic terminals.

Authors:  M S Wyeth; N Zhang; C R Houser
Journal:  Neuroscience       Date:  2011-12-03       Impact factor: 3.590

7.  Depolarizing action of cholecystokinin on rat supraoptic neurones in vitro.

Authors:  C R Jarvis; C W Bourque; L P Renaud
Journal:  J Physiol       Date:  1992-12       Impact factor: 5.182

8.  Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others.

Authors:  Miranda A Karson; Kevin C Whittington; Bradley E Alger
Journal:  Neuropharmacology       Date:  2007-07-01       Impact factor: 5.250

9.  Benzodiazepine/cholecystokinin interactions at functional CCK receptors in rat brain.

Authors:  P R Boden; G N Woodruff
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

10.  Ligand-induced internalization of cholecystokinin receptors. Demonstration of the importance of the carboxyl terminus for ligand-induced internalization of the rat cholecystokinin type B receptor but not the type A receptor.

Authors:  M Pohl; S Silvente-Poirot; J R Pisegna; N I Tarasova; S A Wank
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.